stocktools
Dilution profile // every instrument, one screen, from SEC filings

GLOBUS MEDICAL INC (GMED)

CIK 1237831 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGHS-1/A on file 2012-08-02
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW-3% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2021-02-152026-08-04

Latest: 134.3M shares as of Aug 4, 2026 (10-Q).

Cash runway

Self-funding

profitable · generates cash

Full breakdown: cash runway tool · source filing →

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

NotePrincipalCarryingConv. priceRateIf converted
Senior Convertible Notes Due 2025$450.0M$0not tagged0.375%—

Notes exactly as the company dimensioned them in its 10-Q filed Aug 6, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.

Registrations and offerings

Last 12 months: 0 executed · 0 registered.

EXECUTEDSep 1, 2023Unregistered share sale disclosed (8-K item 3.02)8-K →
UPDATEMar 28, 2023Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEMar 28, 2023SEC declared a registration effective — selling can beginEFFECT →
EXECUTEDAug 3, 2012Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDAug 2, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
MARKETINGAug 2, 2012Free-writing prospectus — offering being marketedFWP →
EFFECTIVEAug 2, 2012SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJul 23, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
MARKETINGJul 23, 2012Free-writing prospectus — offering being marketedFWP →
REGISTEREDJul 16, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDMay 29, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDMay 8, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full GMED workspace